Lasting weight loss results from the #1 clinic in Texas Kickstart your weight loss journey and conquer stubborn, exercise and diet-resistant fat
Observed Effects in Phase 3 Clinical Trials: Notably, these observations derive from Phase 3 human clinical trials with thousands of participants
Put our legal experience to work for you and win your autism benefits.
For example, tirzepatide, a dual GLP-1/GIP agonist, has shown promising results in NASH trials
While none currently carry a specific FDA indication for fatty liver disease or NASH, their metabolic effects provide rationale for use in patients with concurrent hepatic steatosis
If you use oral contraceptives, consider using a backup method of contraception for 4 weeks after starting Zepbound and for 4 weeks after each dose increase